GemPharmatech (SH:688046) Shang Hai Zheng Quan Bao·2025-05-28 19:33Meeting Overview - The annual general meeting of Jiangsu Jicui Yaokang Biotechnology Co., Ltd. was held with no rejected proposals [2] - The meeting was convened by the board of directors and chaired by Chairman Gao Xiang, utilizing a combination of on-site and online voting [2] Attendance - All 9 current directors attended the meeting [3] - All 3 current supervisors were present [3] - The board secretary and CFO, Wang Yihou, also attended the meeting [3] Resolutions Passed - The following proposals were approved during the meeting: 1. 2024 Annual Report and its summary [4] 2. 2024 Board of Directors' Work Report [4] 3. 2024 Supervisory Board Work Report [5] 4. 2024 Financial Settlement Report [5] 5. 2025 Financial Budget Report [5] 6. 2024 Profit Distribution Proposal [5] 7. Reappointment of the auditing firm for 2025 [5] 8. Compensation for directors and supervisors for 2025 [5] 9. Use of raised funds to permanently supplement working capital [5] 10. Expansion of business scope and amendments to the Articles of Association [6] Voting Details - Proposals 1 to 9 were passed with more than half of the voting rights present [6] - Proposal 10 was passed with more than two-thirds of the voting rights present [6] - Separate counting was conducted for proposals 6, 7, 8, and 9 concerning minority investors [6] Legal Verification - The meeting was witnessed by Jiangsu Century Tongren Law Firm, with lawyers confirming the legality of the meeting's procedures and resolutions [6]